Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Perico
G Remuzzi

Showing results (201-210 of 551) with videos related to

Pageof 56
Sort By:
Experimental Nephrology|March 1, 1994
Endothelin and renal disease progressionG Remuzzi, A Benigni
Lancet (London, England)|September 4, 1993
Endothelins in the control of cardiovascular and renal functionG Remuzzi, A Benigni
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1994
The role of eicosanoids in the pathogenesis of hemolytic uremic syndromeA Benigni, G Remuzzi
Lancet (London, England)|July 9, 1983
Stagnations and regressions in the treatment of primary glomerulonephritisT Bertani, G Remuzzi
Medicina (Florence, Italy)|October 1, 1989
[Nephrology]M Abbate, G Remuzzi
Springer Seminars in Immunopathology|January 1, 1994
Inflammation and glomerular injuryA Benigni, G Remuzzi
Current Opinion in Nephrology and Hypertension|November 5, 1997
Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal diseaseP Ruggenenti, G Remuzzi
Blood|October 9, 1999
Uremic bleeding: closing the circle after 30 years of controversies?M Noris, G Remuzzi
Annual Review of Medicine|April 25, 2000
The role of protein traffic in the progression of renal diseasesP Ruggenenti, G Remuzzi
Advances in Nephrology From the Necker Hospital|November 9, 2000
Treatment of adult hemolytic-uremic syndromeP Ruggenenti, G Remuzzi
Pageof 56

Showing results (201-210 of 551) with videos related to

Sort By:
Pageof 56
Experimental Nephrology|March 1, 1994
Endothelin and renal disease progressionG Remuzzi, A Benigni
Lancet (London, England)|September 4, 1993
Endothelins in the control of cardiovascular and renal functionG Remuzzi, A Benigni
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 1, 1994
The role of eicosanoids in the pathogenesis of hemolytic uremic syndromeA Benigni, G Remuzzi
Lancet (London, England)|July 9, 1983
Stagnations and regressions in the treatment of primary glomerulonephritisT Bertani, G Remuzzi
Medicina (Florence, Italy)|October 1, 1989
[Nephrology]M Abbate, G Remuzzi
Springer Seminars in Immunopathology|January 1, 1994
Inflammation and glomerular injuryA Benigni, G Remuzzi
Current Opinion in Nephrology and Hypertension|November 5, 1997
Angiotensin-converting enzyme inhibitor therapy for non-diabetic progressive renal diseaseP Ruggenenti, G Remuzzi
Blood|October 9, 1999
Uremic bleeding: closing the circle after 30 years of controversies?M Noris, G Remuzzi
Annual Review of Medicine|April 25, 2000
The role of protein traffic in the progression of renal diseasesP Ruggenenti, G Remuzzi
Advances in Nephrology From the Necker Hospital|November 9, 2000
Treatment of adult hemolytic-uremic syndromeP Ruggenenti, G Remuzzi
Pageof 56